NVAX - Novavax - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NVAX is currently covered by 5 analysts with an average price target of $34.22. This is a potential upside of $28.03 (452.83%) from yesterday's end of day stock price of $6.19.

Novavax's activity chart (see below) currently has 191 price targets and 142 ratings on display. The stock rating distribution of NVAX is 78.95% BUY, 5.26% HOLD and 15.79% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.64% with an average time for these price targets to be met of 286.29 days.

Highest price target for NVAX is $26, Lowest price target is $7, average price target is $19.

Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 08-May-2025. First documented stock forecast 19-Sep-2014.

Currently out of the existing stock ratings of NVAX, 15 are a BUY (78.95%), 1 are a HOLD (5.26%), 3 are a SELL (15.79%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$7

$1.02 (17.06%)

$9

5 days ago
(08-May-2025)

7/10 (70%)

$1.02 (17.06%)

60

Buy

$19

$13.02 (217.73%)

$19

5 months 4 days ago
(09-Dec-2024)

15/23 (65.22%)

$10.23 (116.65%)

161

Buy

$25

$19.02 (318.06%)

$31

6 months 28 days ago
(15-Oct-2024)

0/5 (0%)

$14.85 (146.31%)

Buy

$26

$20.02 (334.78%)

$23

7 months 4 days ago
(09-Oct-2024)

17/42 (40.48%)

$13.09 (101.39%)

85

Hold

$18

$12.02 (201.00%)

$13

11 months ago
(13-Jun-2024)

3/4 (75%)

$3.6 (25.00%)

228

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NVAX (Novavax) average time for price targets to be met?

On average it took 286.29 days on average for the stock forecasts to be realized with a an average price target met ratio 65.64

Which analyst has the current highest performing score on NVAX (Novavax) with a proven track record?

HEATHER BEHANNA

Which analyst has the most public recommendations on NVAX (Novavax)?

Heather Behanna has 12 price targets and 10 ratings on NVAX

Which analyst is the currently most bullish on NVAX (Novavax)?

Heather Behanna with highest potential upside - $272.76

Which analyst is the currently most reserved on NVAX (Novavax)?

Edward Tenthoff with lowest potential downside - -$0.98

Novavax in the News

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

On Thursday, Novavax Inc. (NASDAQ:NVAX) reported first-quarter 2025 sales of $667 million, compared to $94 million a year ago, beating the consensus of $343.85 million. Higher product sales for the first quarter of 2025 were primarily due to $603 million of revenue recognized with the termination of two Advance Purchase Agreements (APA) and related to cash received in prior...

Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears

By Sriparna Roy (Reuters) – Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S. regulators saying that it sees a pathway to resolving issues with the FDA, sending shares up nearly 19% in early trading. The vaccine maker said it believes commitments to...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?